Found 17 matching trials
Predictive Factors to Effectively Terminate Paroxysmal Atrial Fibrillation by Blocking Atrial Selective Ionic Currents
PHASE4* The main objective of this project is to study the efficacy and the mecha...
Location
Hospital Clínico Universitario San Carlos
A Study Comparing Vernakalant Therapy to Amiodarone Therapy in Acute Management of Recent Onset Atrial Fibrillation (AF) (MK-6621-055)
PHASE4This study will compare vernakalant therapy to amiodarone therapy in the ac...
Location
Multiple Locations
Study of RSD1235 to Evaluate Safety in Patients With Atrial Fibrillation
PHASE3This study is designed to determine the safety of RSD1235 in patients with ...
Location
Multiple Locations
A Phase III Superiority Study of Vernakalant vs Amiodarone in Subjects With Recent Onset Atrial Fibrillation
PHASE3The primary objective of the study is to demonstrate the superiority of ver...
Location
Royal Adelaide Hospital
Phase III Tolerance and Efficacy Study of RSD1235 in Patients With Atrial Fibrillation
PHASE3This study is being conducted to demonstrate the effectiveness of RSD1235 i...
Location
University of California
Response to RSD1235 Compared to Placebo in Subjects With Atrial Arrhythmia After Heart Surgery
PHASE3The purpose of this study is to demonstrate the safety and efficacy of RSD1...
Location
Multiple Locations
A Phase II/III Tolerance and Efficacy Study of RSD1235 in Patients With Atrial Flutter
PHASE2This study will attempt to demonstrate the effectiveness of RSD1235 in the ...
Location
Regional Cardiology Associates
A Phase 3b Study of Vernakalant Injection in Patients With Recent Onset Symptomatic Atrial Fibrillation (AF)(MK-6621-045)
PHASE3The purpose of this study is to evaluate the safety and efficacy of vernaka...
Location
Multiple Locations
Study of Normal Conditions of Use, Dosing, and Safety of Intravenous (IV) Administration of Vernakalant (MK-6621-049)
N/AThis non-interventional prospective study is a post-authorization safety st...
Location
Medizinische Universitat Wien
A Study of the Efficacy and Safety of Vernakalant Hydrochloride (MK-6621) in Patients With Atrial Fibrillation (MK-6621-010 AM4)
PHASE3This study will investigate if treatment with vernakalant hydrochloride (MK...
Location
Multiple Locations